TH — Target Hospitality Corp. Stock Price, Chart & AI Report

Neutral Apr 2, 2026 • 13:30 UTC Benzinga • Rishabh Mishra

Stock Market Today: S&P 500, Nasdaq Futures Plunge As Trump 'Re-Escalates' War With Iran— Micron Technology, IBM, General Motors In Focus (UPDATED)

U.S. stock futures declined sharply on Thursday as President Trump escalated military tensions with Iran, threatening strikes on Iranian infrastructure for another two to three weeks. The S&P 500, Dow, and Nasdaq 100 all fell in premarket trading, with crude oil rising 6.74% amid geopolitical uncertainty. Key stocks including Micron Technology, General Motors, and IBM experienced declines, while analyst sentiment remains cautiously optimistic on long-term U.S. economic growth despite near-term volatility.

MU GM IBM LMT geopolitical tension Iran escalation market volatility crude oil

Sentiment note

Stock declined 0.079% despite securing $550 million data center contract and raising FY26 sales guidance. Strong price trends across all timeframes suggest positive fundamentals despite minor decline.

Negative Aug 7, 2025 • 13:11 UTC The Motley Fool • Jesterai

Target Hospitality (TH) Q2 Revenue Up 9%

Target Hospitality reported Q2 2025 revenue of $61.6 million, beating analyst expectations, but experienced significant profitability challenges due to terminated government contracts. The company raised full-year guidance and is focusing on diversifying revenue streams through new long-term contracts.

TH workforce lodging hospitality services government contracts revenue diversification

Sentiment note

Despite beating revenue estimates, the company experienced a 38.8% revenue decline, 93.3% drop in Adjusted EBITDA, and significant losses from terminated government contracts. The negative impacts were partially offset by new contract wins and raised guidance.

Negative Aug 27, 2024 • 01:00 UTC GlobeNewswire Inc. • N/A

Bragar Eagel & Squire, P.C. Is Investigating Metagenomi, Target Hospitality, Helios, and LegalZoom and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential securities law violations and other unlawful business practices by Metagenomi, Target Hospitality, Helios, and LegalZoom.

MGX TH HLIO LZ Metagenomi Target Hospitality Helios LegalZoom

Sentiment note

Target Hospitality's stock price fell significantly after the company announced the termination of its services agreement with the U.S. government.

Unknown Jun 26, 2024 • 11:30 UTC GlobeNewswire Inc. • Theratechnologies

Theratechnologies annoncera ses résultats financiers du deuxième trimestre de l’exercice financier de 2024 et fera une mise à jour de ses activités

MONTRÉAL, 26 juin 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur le développement et la commercialisation de traitements innovateurs, annonce aujourd’hui que la Société dévoilera ses résultats pour le deuxième trimestre de l’exercice financier de 2024, clos le 31 mai 2024, et fera le point sur ses activités, le mercredi 10 juillet 2024, à 8 h 30 (HE).

TH THTX Calendar of Events

Unknown Jun 26, 2024 • 11:30 UTC GlobeNewswire Inc. • Theratechnologies

Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update

MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its second quarter ended May 31, 2024, on Wednesday, July 10 at 8:30 a.m. ET.

TH THTX Calendar of Events

Unknown Jun 4, 2024 • 13:15 UTC Zacks Investment Research • Zacks Equity Research

Royal Caribbean Cruises Ltd. (RCL) Hits Fresh High: Is There Still Room to Run?

Royal Caribbean (RCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

RCL TH

Unknown May 29, 2024 • 13:40 UTC Zacks Investment Research • Zacks Equity Research

Are Investors Undervaluing Target Hospitality (TH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

TH

Unknown May 23, 2024 • 21:00 UTC GlobeNewswire Inc. • Theratechnologies

Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

MONTREAL, May 23, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced Phase 1 data demonstrating signs of long-term efficacy and a manageable safety profile of its lead investigational peptide drug conjugate (PDC) candidate, sudocetaxel zendusortide (TH1902), in patients with solid tumors. The data will be presented in a poster session on June 1, 9:00 AM-12:00 PM CDT (abstract #3081, poster board #226) at the 2024 American Society of Clinical Oncology (ASCO) annual meeting, which is taking place May 31-June 4, 2024, in Chicago, IL.

TH THTX Calendar of Events Health Trade Show

Unknown May 23, 2024 • 21:00 UTC GlobeNewswire Inc. • Theratechnologies

Theratechnologies fait une présentation sur le sudocétaxel zendusortide au Congrès 2024 de l’ASCO qui montre des signes d’une efficacité à long terme et un profil d’innocuité gérable chez les patients atteints de tumeurs solides

MONTRÉAL, 23 mai 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée sur la mise au point et la commercialisation de traitements novateurs, a annoncé aujourd’hui des données de phase I établissant des signes d’efficacité à long terme et un profil d’innocuité gérable de son principal conjugué peptide-médicament (CPM) expérimental, le sudocétaxel zendusortide (TH1902), dans le traitement de patients atteints de tumeurs solides. Les données seront présentées dans le cadre d’une séance d’affiches le 1er juin, de 9 h à 12 h (HAC) (résumé no 3081, panneau d’affichage no 226) au Congrès 2024 de l’ASCO (American Society of Clinical Oncology) qui aura lieu du 31 mai au 4 juin 2024, à Chicago (Illinois).

TH THTX Calendar of Events Health Trade Show

Unknown May 17, 2024 • 13:15 UTC Zacks Investment Research • Zacks Equity Research

Royal Caribbean Cruises Ltd. (RCL) Hit a 52 Week High, Can the Run Continue?

Royal Caribbean (RCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

RCL TH

Unknown May 14, 2024 • 16:20 UTC Zacks Investment Research • Zacks Equity Research

Surging Earnings Estimates Signal Upside for Target Hospitality (TH) Stock

Target Hospitality (TH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

TH

Unknown May 13, 2024 • 16:00 UTC Zacks Investment Research • Zacks Equity Research

Target Hospitality (TH) Upgraded to Buy: Here's What You Should Know

Target Hospitality (TH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TH